Abstract | AIM: Brazilian newborns immunized with hepatitis-B ( thimerosal containing vaccine, TCV) receive the first dose within 24 h if delivered in public hospitals, but at a later time if born in private hospitals. We compared neurodevelopment (ND) in infants born in a state hospital (immunized within 24 h) and in privately run hospitals (immunized 2-4 days postnatally). METHODS: We used the Gesell Developmental Schedules in 82 healthy exclusively breastfed infants at 6 months to assess motor skills, language development, comprehension capacity and social skills. RESULTS: Compared to the group immunized 2-4 days after hospital discharge, the group immunized within 24 h showed no significant difference in ND delays. Despite the variation in gestational age (range 36-42 weeks) and TCV-ethylmercury (EtHg) dose (5.7-11.3 microg Hg/kg b.w.) at birth, time of exposure to TCV showed no significant association with ND. Gesell Developmental Score was not significantly correlated with total parenteral EtHg/unit of body mass neither with the relative increase in hair-Hg (as an additional challenge to prenatal Hg exposure). CONCLUSION: In breastfed infants, differences in early exposure to TCV-EtHg cannot portend clinical neurodevelopment delays at 6 months. We speculate that breastfeeding remains a significant strategy to improve central nervous system protection of infants facing early exposure challenges.
|
Authors | Rejane C Marques, José G Dórea, Angelo G Manzatto, Wanderley R Bastos, José V E Bernardi, Olaf Malm |
Journal | Acta paediatrica (Oslo, Norway : 1992)
(Acta Paediatr)
Vol. 96
Issue 6
Pg. 864-8
(Jun 2007)
ISSN: 0803-5253 [Print] Norway |
PMID | 17465985
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Ethylmercury Compounds
- Hepatitis B Vaccines
- Preservatives, Pharmaceutical
- Thimerosal
|
Topics |
- Body Weight
- Brazil
- Breast Feeding
- Developmental Disabilities
(chemically induced)
- Ethylmercury Compounds
(administration & dosage, adverse effects)
- Female
- Hepatitis B Vaccines
(administration & dosage, chemistry)
- Humans
- Immunization Schedule
- Infant, Newborn
- Male
- Maximum Tolerated Dose
- Neuropsychological Tests
- Preservatives, Pharmaceutical
(administration & dosage, adverse effects)
- Thimerosal
(administration & dosage, adverse effects)
- Time Factors
|